Core Viewpoint - Lianchi Hospital Group has officially submitted its prospectus to the Hong Kong Stock Exchange for an initial public offering (IPO), marking a significant step in its capital market strategy [1] Company Overview - Lianchi Hospital Group focuses on specialized medical services, particularly in the "elderly and children" healthcare sector, operating five hospitals and one elderly care institution [3] - The group has a total construction area of 117,900 square meters and 786 registered beds, supported by a medical team of 341 practitioners [3] Operational Performance - The outpatient visits for the years 2023 to the first nine months of 2025 were 355,900, 403,200, and 321,300 respectively, while inpatient visits were 9,900, 13,300, and 11,400 [3] - The number of orthopedic surgeries increased from 3,655 in 2023 to 4,189 in 2024, with 4,180 completed in the first nine months of 2025 [3] - The number of deliveries rose from 3,304 to 5,055, with 3,758 deliveries recorded in the first nine months of 2025 [3] Market Position - According to a report by Frost & Sullivan, Lianchi Hospital's Zibo branch ranks first in Shandong Province and third nationwide in terms of knee surgery volume among private hospitals for 2024, highlighting its competitive advantage in the orthopedic specialty field [4] - The submission of the prospectus signifies a new phase in Lianchi Hospital's path to capitalization, with its ability to gain investor recognition in the Hong Kong market being a point of ongoing interest [4]